uniQure N.V [QURE] stock is trading at $9.65, up 5.23%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The QURE shares have gain 15.71% over the last week, with a monthly amount drifted -33.59%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Raymond James upgraded its rating to Strong Buy on December 10, 2024. Goldman downgraded its rating to a Neutral but stick to its price target of $8 on February 29, 2024. Mizuho downgraded its rating to a Neutral and reduced its price target to $10 on December 19, 2023. UBS upgraded its rating to Buy for this stock on March 17, 2022, but kept the price target unchanged to $40. In a note dated June 15, 2021, BTIG Research initiated an Buy rating and provided a target price of $46 on this stock.
uniQure N.V [QURE] stock has fluctuated between $3.73 and $19.18 over the past year. Currently, Wall Street analysts expect the stock to reach $27 within the next 12 months. uniQure N.V [NASDAQ: QURE] shares were valued at $9.65 at the most recent close of the market. An investor can expect a potential return of 179.79% based on the average QURE price forecast.
Analyzing the QURE fundamentals
uniQure N.V [NASDAQ:QURE] reported sales of 27.12M for the trailing twelve months, which represents a drop of -21.95%. Gross Profit Margin for this corporation currently stands at 0.13% with Operating Profit Margin at -6.96%, Pretax Profit Margin comes in at -8.74%, and Net Profit Margin reading is -8.83%. To continue investigating profitability, this company’s Return on Assets is posted at -0.43, Equity is -3.27 and Total Capital is -0.37. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -9.78.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 9.24 points at the first support level, and at 8.82 for the second support level. However, for the 1st resistance point, the stock is sitting at 9.89, and for the 2nd resistance point, it is at 10.13.
Ratios To Look Out For
For context, uniQure N.V’s Current Ratio is 9.74. Further, the Quick Ratio stands at 9.74, while the Cash Ratio is 3.97. Considering the valuation of this stock, the price to sales ratio is 19.24.
Transactions by insiders
Recent insider trading involved Kapusta Matthew C, CEO, Managing Director, that happened on Mar 04 ’25 when 28341.0 shares were sold. Chief Medical Officer, Abi-Saab Walid completed a deal on Mar 04 ’25 to sell 1350.0 shares. Meanwhile, Chief Financial Officer KLEMT CHRISTIAN sold 10438.0 shares on Mar 04 ’25.
